Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

353.93 +5.50 (+1.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
64 65 Next >
News headline image
Is Amgen The Rare Biotech With A Safe Dividend? ↗
Amgen pays a $2.25 per share quarterly dividend, which comes out to a 3.3% yield. Biotech can be notoriously volatile, though, so can investors count on receiving the same dividend quarter after... 
Via Talk Markets
News headline image
7 Analysts Have This To Say About Amgen ↗
 
Via Benzinga
News headline image
Biotech Sector Nears Breakout: Will it Outperform in Q2?
The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains 
Via MarketBeat
Topics ETFs
News headline image
5 Healthcare Stocks to Buy for 2024 ↗
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Amgen Unusual Options Activity For April 02 ↗
 
Via Benzinga
News headline image
Amgen Options Trading: A Deep Dive into Market Sentiment ↗
 
Via Benzinga
News headline image
Is Amgen Stock a Buy Now? ↗
There are some worrying signs. 
Via The Motley Fool
News headline image
Looking At Amgen's Recent Unusual Options Activity ↗
 
Via Benzinga
News headline image
(AMGN) - Analyzing Amgen's Short Interest ↗
 
Via Benzinga
News headline image
Redditors Identify 'Best Undervalued Stocks' For 2024 ↗
Savvy investors at Reddit discuss undervalued stocks for potential growth. Top picks include META, Google, Starbucks, Verizon, and others, with varied perspectives on their potential. 
Via Benzinga
News headline image
Amgen's Diversified Portfolio To Drive Long-Term Growth, Though Uncertainties Loom, Analyst Says ↗
Raymond James resumes coverage of Amgen highlighting its diversified portfolio and strong presence across therapeutic areas for sustainable long-term growth. Innovative pipeline in oncology, rare... 
Via Benzinga
News headline image
7 Stocks That Will Drive the Weight Loss Drugs Market
The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis. 
Via MarketBeat
News headline image
3 Biotech Stocks to Buy on the Dip: March 2024 ↗
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. 
Via InvestorPlace
News headline image
7 Dow Stocks to Buy on the Dip: March 2024 ↗
Analysts expect that the market may be heading toward a correction. These are seven of the best Dow stocks to buy when prices pull back. 
Via InvestorPlace
Topics Stocks
News headline image
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich ↗
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom. 
Via InvestorPlace
News headline image
Buffett’s Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating ↗
Warren Buffett stocks and Berkshire Hathaway's portfolio of companies are hidden investment vehicles hiding in plain sight. 
Via InvestorPlace
News headline image
Hot Stocks: The 3 Best Opportunities for Investing in Biotech ↗
Biotech stocks can offer some of the best risk vs. reward payoff in the stock market. These three are ones to buy now. 
Via InvestorPlace
News headline image
Hot Stocks: The 3 Best Opportunities for Investing in the Dow ↗
Although these Dow stocks are mature enterprises, they still have enough in the tank to pull off some surprises. 
Via InvestorPlace
Topics Stocks
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
4 Oversold Large Cap Stocks Yielding High Dividends
Overlooked, oversold large-cap stocks offer compelling dividend yields for investors seeking income and potential capital appreciation 
Via MarketBeat
Topics Artificial Intelligence Economy
News headline image
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields ↗
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
News headline image
The Dow’s Best Friends: 3 ‘Dogs’ Ready to Fetch Huge Returns ↗
The Dogs of the Dow strategy is one of the best yearly strategies investors should use to make some good money. 
Via InvestorPlace
Topics Stocks
News headline image
Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks ↗
With therapeutics focused on slimming down skyrocketing, it’s time to consider these top weight-loss stocks. 
Via InvestorPlace
News headline image
The AI Race Gets Litigious ↗
We've also got a look at the role of patents in pharmaceuticals and the "patent cliff" looming over the next decade. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
9 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029 ↗
Explore President Biden's plan to expand Medicare drug negotiations, targeting at least 50 drugs annually. Uncover the impact on pharmaceutical profits and the broader health-care policy proposals,... 
Via Benzinga
News headline image
Is It Time to Buy February's 3 Worst-Performing Dow Jones Stocks? ↗
It's only a bargain price if it's actually worth owning. 
Via The Motley Fool
Topics Stocks
News headline image
It’s Time! 3 Dodgy Pharma Stocks to Sell in February ↗
Explore pharma stocks to sell in February: Eli Lilly, Amgen, BioNTech face overvaluation, volatility, urging investor action. 
Via InvestorPlace
News headline image
After Soaring 222% in 1 Day, Is Janux Therapeutics Stock a Buy? ↗
The biotech tantalized investors with a very promising data update. 
Via The Motley Fool
News headline image
Eli Lilly Stock And The Road To 1,000: Weight-Loss Drugs Could Generate $81 Billion ↗
Wall Street isn't properly taking into account Lilly's next-generation drugs, an analyst says. 
Via Investor's Business Daily
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.